DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Chemokine signaling pathway	R-HSA-168638	map04062	anisomycin	60198	drug-path
Regulation of actin cytoskeleton	R-HSA-392751	map04810	anisomycin	60198	drug-path
Parkinson's disease	R-HSA-1643685	0	anisomycin	60198	drug-path
Cardiac muscle contraction	R-HSA-397014	map04260	anisomycin	60198	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	anisomycin	60198	drug-path
Ribosome	R-HSA-5368277	map03010	anisomycin	60198	drug-path
Calcium signaling pathway	R-HSA-381753	map04020	anisomycin	60198	drug-path
Proteasome	R-HSA-68819	map03050	anisomycin	60198	drug-path
Vascular smooth muscle contraction	R-HSA-445355	map04270	anisomycin	60198	drug-path
Basal cell carcinoma	R-HSA-5626181	map05217	anisomycin	60198	drug-path
ABC transporters	R-HSA-1369007	map02010	anisomycin	60198	drug-path
Apoptosis	R-HSA-109581	map04210	anisomycin	60198	drug-path
Jak-STAT signaling pathway	R-HSA-168638	map04630	anisomycin	60198	drug-path
Olfactory transduction	R-HSA-9751605	map04740	stachydrine	115244	drug-path
Adherens junction	R-HSA-451386	map04520	stachydrine	115244	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	stachydrine	115244	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	dipivefrine	3105	drug-path
B cell receptor signaling pathway	R-HSA-983705	map04662	dipivefrine	3105	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	dipivefrine	3105	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	dipivefrine	3105	drug-path